TIORFAN 4 mg/ml for infants and for children, oral suspension bottle, 50 ml
Active ingredients: Racecadotril
Commercialized according to BDPMDispensing in France: Prescription only
Oral suspensionbottle, 50 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TIORFAN 4 mg/mL NOURRISSONS ET ENFANTS, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon polytéréphtalate (PET) avec fermeture de sécurité enfant de 50 mL avec seringue de 10 mL graduée en kg
- Marketing authorisation holder
- BIOPROJET PHARMA (FRANCE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Oct 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60111471CIP73017384CIP133400930173848Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RACÉCADOTRILsuspension | 4 mg · 1 mL de suspension | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.